• Baby blues encompassing depression, anxiety, and long periods of crying is experienced by nearly 85% of women either during or after pregnancy.

• But despite prevalence in a majority this aspect of maternal health is wrought with taboos and stigma worldwide.

• These misconceptions result in misplaced guilt and fear to seek help among women.

• These obstacles to maternal mental health must be identified early and tackled promptly to safeguard healthy development and wellbeing of mother and child.

• The US FDA recently approved Zuranolone, a fast acting antidepressant making it the second approved pharmacotherapy for postpartum depression.

• Further research is direly needed to evaluate efficacy of existing and exploration of new treatment options.

• Raising awareness, conducting screening to identify perinatal depression and designing effective preventive interventions is the need of the hour.

Click here to read more